<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02867605</url>
  </required_header>
  <id_info>
    <org_study_id>16-142</org_study_id>
    <nct_id>NCT02867605</nct_id>
  </id_info>
  <brief_title>Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether oral HA35 supplementation changes the normal&#xD;
      intestinal bacteria, increases intestinal protection, decrease intestinal inflammation and&#xD;
      permeability, and to assess any health benefits and confirm the safety profile of HA35.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Actual">June 20, 2019</completion_date>
  <primary_completion_date type="Actual">September 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composition of Stool Micro Biome Diversity and Phylogenetic Distribution at 0 Days, 8 Days and 28 Days</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
    <description>Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. As an example a relative abundance of firmicutes equal to 0.9 would mean that 90% of the bacteria identified in a sample are firmicutes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laboratory Parameters at Day 0, Day 8 and 28 Calcium, Bilirubin, Glucose, Blood Urea Nitrogen, Creatinine</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Indirect Calorimetry Data at 0 Day, 8 Days and 28 Days Volume of Oxygen and Volume Carbon Dioxide</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Indirect Calorimetry Data at 0 Day, 8 Days and 28 Days Respiratory Quotient RQ</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
    <description>The respiratory quotient is a ratio between the volume of carbon dioxide exhaled and the volume of oxygen inhaled during respiration. It typically ranges between 0.7 and 1.0 and is an indicator of metabolic fuel or substrate use in tissues; it must be calculated under resting or steady-state exercise conditions. A ratio of 0.7 is indicative of mixed fat use, whereas a ratio of 1.0 indicates the exclusive use of carbohydrates</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal Intestinal Antimicrobial Peptide Secretion at 0 Days, 8 Days and 28 Days Total Protein</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal Intestinal Antimicrobial Peptide Secretion at 0 Days, 8 Days and 28 Days Normalized Calprotectin and Human Beta-Defensin2</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Indicators of Intestinal Permeability at 0 Days, 8 Days and 28 Days Serum Lipopolysaccharide, Hyaluronan</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Indicators of Inflammation and Injury at Baseline, 8 Days and 28 Days-tumor Necrosis Factor (TNF) Alpha, Interleukin 6 (IL-6)</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Baseline Serum Indicators of Inflammation and Injury at Baseline, 8 Days and 28 Days-C-reactive Protein</measure>
    <time_frame>Baseline, Day 8, Day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Protein, Hemoglobin and Albumin Levels at Baseline, Day 8, and Day 28</measure>
    <time_frame>Baseline, day 8 day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>White Blood Cell and Platelet Count at Baseline, Day 8, and Day 28</measure>
    <time_frame>baseline, day 8, and day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Alkaline Phosphatase, Alanine Transaminase , and Aspartate Transaminase at Baseline, Day 8, and Day 28</measure>
    <time_frame>baseline, day 8, and day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Sodium, Potassium, and Carbon Dioxide at Baseline Day 8 and Day 28</measure>
    <time_frame>baseline, day 8, and day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Resting Energy Expenditure (REE) and Metabolic Rate at Baseline Day 8 an Day 28</measure>
    <time_frame>Baseline, day 8, and day 28</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Resting Energy Expenditure as a Percent of Predicted at Baseline, Day 8, and Day 28</measure>
    <time_frame>Baseline, day 8, and day 28</time_frame>
    <description>This values measures the amount of energy a person uses during rest and compares it the average expected number of someone who is the same gender, age, and race.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Gastrointestinal Microbiome</condition>
  <arm_group>
    <arm_group_label>Healthy Controls ages 18-45 with BMI of 19-25 or 30-35</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single Arm study</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Hyaluronan</intervention_name>
    <arm_group_label>Healthy Controls ages 18-45 with BMI of 19-25 or 30-35</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI 19-25 (lean), and BMI 30-35 (obese)&#xD;
&#xD;
          -  Age 18-45 years old&#xD;
&#xD;
          -  Willingness to take oral supplement and adhere to study requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Oral antibiotics within 4 weeks of study initiation&#xD;
&#xD;
          -  History of cardiac disease, and medications for cardiac disease&#xD;
&#xD;
          -  Use statins and antihypertensive drugs&#xD;
&#xD;
          -  Inflammatory bowel disease including irritable bowel syndrome&#xD;
&#xD;
          -  History of intestinal surgery, excluding hernia repair and appendectomy&#xD;
&#xD;
          -  Active cancer diagnosis (except skin cancer)&#xD;
&#xD;
          -  Chronic acid suppression treatment (proton pump inhibitors, histamine H2 receptor&#xD;
             antagonists)&#xD;
&#xD;
          -  Immune modulatory treatments (e.g. chronic immunosuppressive medications, chronic&#xD;
             NSAIDs)&#xD;
&#xD;
          -  Vegetarian or vegan diet7&#xD;
&#xD;
          -  Abnormal liver or kidney function as measured by routine serum chemistry testing&#xD;
&#xD;
          -  Severe anemia or significant white blood cell or platelet abnormalities&#xD;
&#xD;
          -  No additional blood or blood product donations during the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hill DR, Kessler SP, Rho HK, Cowman MK, de la Motte CA. Specific-sized hyaluronan fragments promote expression of human Î²-defensin 2 in intestinal epithelium. J Biol Chem. 2012 Aug 31;287(36):30610-24. doi: 10.1074/jbc.M112.356238. Epub 2012 Jul 3.</citation>
    <PMID>22761444</PMID>
  </reference>
  <reference>
    <citation>Hill DR, Rho HK, Kessler SP, Amin R, Homer CR, McDonald C, Cowman MK, de la Motte CA. Human milk hyaluronan enhances innate defense of the intestinal epithelium. J Biol Chem. 2013 Oct 4;288(40):29090-104. doi: 10.1074/jbc.M113.468629. Epub 2013 Aug 15.</citation>
    <PMID>23950179</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 9, 2016</study_first_submitted>
  <study_first_submitted_qc>August 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <results_first_submitted>February 21, 2020</results_first_submitted>
  <results_first_submitted_qc>July 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 13, 2020</results_first_posted>
  <last_update_submitted>August 19, 2020</last_update_submitted>
  <last_update_submitted_qc>August 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Carol De La Motte</investigator_full_name>
    <investigator_title>Assoiciate Staff</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 18, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/05/NCT02867605/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Healthy Controls Ages 18-45 With BMI of 19-25 or 30-35</title>
          <description>Hyaluronan</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Healthy Controls Ages 18-45 With BMI of 19-25 or 30-35</title>
          <description>Hyaluronan</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.7" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composition of Stool Micro Biome Diversity and Phylogenetic Distribution at 0 Days, 8 Days and 28 Days</title>
        <description>Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. As an example a relative abundance of firmicutes equal to 0.9 would mean that 90% of the bacteria identified in a sample are firmicutes</description>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre Treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 day treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Composition of Stool Micro Biome Diversity and Phylogenetic Distribution at 0 Days, 8 Days and 28 Days</title>
          <description>Relative abundance is defined as the proportion of total identified bacteria in a sample that are a given type of bacteria. As an example a relative abundance of firmicutes equal to 0.9 would mean that 90% of the bacteria identified in a sample are firmicutes</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>firmicutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.697" spread="0.164"/>
                    <measurement group_id="O2" value="0.722" spread="0.133"/>
                    <measurement group_id="O3" value="0.735" spread="0.118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>actinobacteria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.146" spread="0.0985"/>
                    <measurement group_id="O2" value="0.145" spread="0.111"/>
                    <measurement group_id="O3" value="0.141" spread="0.0951"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>bacteroidetes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0969" spread="0.0855"/>
                    <measurement group_id="O2" value="0.00789" spread="0.0497"/>
                    <measurement group_id="O3" value="0.101" spread="0.102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>verrucomicrobia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0415" spread="0.117"/>
                    <measurement group_id="O2" value="0.0398" spread="0.115"/>
                    <measurement group_id="O3" value="0.0151" spread="0.0273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>proteobacteria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0111" spread="0.0211"/>
                    <measurement group_id="O2" value="0.00789" spread="0.0118"/>
                    <measurement group_id="O3" value="0.00432" spread="0.00509"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>euryarchaeota</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00381" spread="0.00797"/>
                    <measurement group_id="O2" value="0.00295" spread="0.00558"/>
                    <measurement group_id="O3" value="0.00221" spread="0.00463"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>tenericutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00275" spread="0.00605"/>
                    <measurement group_id="O2" value="0.00267" spread="0.00602"/>
                    <measurement group_id="O3" value="0.00152" spread="0.00322"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>unclassified</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.000272" spread="0.00000633"/>
                    <measurement group_id="O2" value="0.000243" spread="0.00000618"/>
                    <measurement group_id="O3" value="0.000237" spread="0.00000733"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>others</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.000359" spread="0.000589"/>
                    <measurement group_id="O2" value="0.000134" spread="0.000247"/>
                    <measurement group_id="O3" value="0.000183" spread="0.00031"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Laboratory Parameters at Day 0, Day 8 and 28 Calcium, Bilirubin, Glucose, Blood Urea Nitrogen, Creatinine</title>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre Treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 days of treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Laboratory Parameters at Day 0, Day 8 and 28 Calcium, Bilirubin, Glucose, Blood Urea Nitrogen, Creatinine</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Calcium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" spread="0.4"/>
                    <measurement group_id="O2" value="9.2" spread="0.2"/>
                    <measurement group_id="O3" value="9.1" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin (total)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.3"/>
                    <measurement group_id="O2" value="0.4" spread="0.2"/>
                    <measurement group_id="O3" value="0.4" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" spread="20"/>
                    <measurement group_id="O2" value="94" spread="16"/>
                    <measurement group_id="O3" value="89" spread="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>blood urea nitrogen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" spread="3"/>
                    <measurement group_id="O2" value="11" spread="4"/>
                    <measurement group_id="O3" value="12" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="0.16"/>
                    <measurement group_id="O2" value="0.85" spread="0.16"/>
                    <measurement group_id="O3" value="0.83" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Indirect Calorimetry Data at 0 Day, 8 Days and 28 Days Volume of Oxygen and Volume Carbon Dioxide</title>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/ Pretreatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>immediately post treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Indirect Calorimetry Data at 0 Day, 8 Days and 28 Days Volume of Oxygen and Volume Carbon Dioxide</title>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>volume oxygen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.225" spread="0.041"/>
                    <measurement group_id="O2" value="0.224" spread="0.039"/>
                    <measurement group_id="O3" value="0.239" spread="0.048"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>volume carbon dioxide</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.180" spread="0.029"/>
                    <measurement group_id="O2" value="0.184" spread="0.035"/>
                    <measurement group_id="O3" value="0.197" spread="0.038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Indirect Calorimetry Data at 0 Day, 8 Days and 28 Days Respiratory Quotient RQ</title>
        <description>The respiratory quotient is a ratio between the volume of carbon dioxide exhaled and the volume of oxygen inhaled during respiration. It typically ranges between 0.7 and 1.0 and is an indicator of metabolic fuel or substrate use in tissues; it must be calculated under resting or steady-state exercise conditions. A ratio of 0.7 is indicative of mixed fat use, whereas a ratio of 1.0 indicates the exclusive use of carbohydrates</description>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/pretreatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 days of treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Indirect Calorimetry Data at 0 Day, 8 Days and 28 Days Respiratory Quotient RQ</title>
          <description>The respiratory quotient is a ratio between the volume of carbon dioxide exhaled and the volume of oxygen inhaled during respiration. It typically ranges between 0.7 and 1.0 and is an indicator of metabolic fuel or substrate use in tissues; it must be calculated under resting or steady-state exercise conditions. A ratio of 0.7 is indicative of mixed fat use, whereas a ratio of 1.0 indicates the exclusive use of carbohydrates</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.808" spread="0.077"/>
                    <measurement group_id="O2" value="0.822" spread="0.061"/>
                    <measurement group_id="O3" value="0.826" spread="0.0708"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fecal Intestinal Antimicrobial Peptide Secretion at 0 Days, 8 Days and 28 Days Total Protein</title>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pretreatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 day treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Fecal Intestinal Antimicrobial Peptide Secretion at 0 Days, 8 Days and 28 Days Total Protein</title>
          <units>ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22883.8" spread="6425.7"/>
                    <measurement group_id="O2" value="22365.3" spread="5872.8"/>
                    <measurement group_id="O3" value="22726.3" spread="6305.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fecal Intestinal Antimicrobial Peptide Secretion at 0 Days, 8 Days and 28 Days Normalized Calprotectin and Human Beta-Defensin2</title>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/pretreatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 days of treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Fecal Intestinal Antimicrobial Peptide Secretion at 0 Days, 8 Days and 28 Days Normalized Calprotectin and Human Beta-Defensin2</title>
          <units>ng/ug</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>calprotectin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00627" spread="0.0033"/>
                    <measurement group_id="O2" value="0.00828" spread="0.005886"/>
                    <measurement group_id="O3" value="0.00891" spread="0.00557"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>human beta-Defensin2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0042" spread="0.00660"/>
                    <measurement group_id="O2" value="0.00535" spread="0.01046"/>
                    <measurement group_id="O3" value="0.00362" spread="0.00814"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serum Indicators of Intestinal Permeability at 0 Days, 8 Days and 28 Days Serum Lipopolysaccharide, Hyaluronan</title>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/PreTreatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately Post 7 days of treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Indicators of Intestinal Permeability at 0 Days, 8 Days and 28 Days Serum Lipopolysaccharide, Hyaluronan</title>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Lipopolysaccharide</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.409" spread="1.347"/>
                    <measurement group_id="O2" value="2.677" spread="5.959"/>
                    <measurement group_id="O3" value="1.256" spread="4.029"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyaluronan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="338.8" spread="82.8"/>
                    <measurement group_id="O2" value="329.0" spread="106.6"/>
                    <measurement group_id="O3" value="338.7" spread="73.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serum Indicators of Inflammation and Injury at Baseline, 8 Days and 28 Days-tumor Necrosis Factor (TNF) Alpha, Interleukin 6 (IL-6)</title>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/ Pretreatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 days of treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Indicators of Inflammation and Injury at Baseline, 8 Days and 28 Days-tumor Necrosis Factor (TNF) Alpha, Interleukin 6 (IL-6)</title>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TNF alpha</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="5.1"/>
                    <measurement group_id="O2" value="2.4" spread="6.6"/>
                    <measurement group_id="O3" value="3.2" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>interleukin 6 (IL-6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.6" spread="14.6"/>
                    <measurement group_id="O2" value="11.7" spread="16.8"/>
                    <measurement group_id="O3" value="10.5" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Baseline Serum Indicators of Inflammation and Injury at Baseline, 8 Days and 28 Days-C-reactive Protein</title>
        <time_frame>Baseline, Day 8, Day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre-treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>immediately post 7 days of treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Serum Indicators of Inflammation and Injury at Baseline, 8 Days and 28 Days-C-reactive Protein</title>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" spread="15.5"/>
                    <measurement group_id="O2" value="10.3" spread="12.8"/>
                    <measurement group_id="O3" value="11.6" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Blood Protein, Hemoglobin and Albumin Levels at Baseline, Day 8, and Day 28</title>
        <time_frame>Baseline, day 8 day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre Treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 day treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Protein, Hemoglobin and Albumin Levels at Baseline, Day 8, and Day 28</title>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hemoglobin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.4" spread="1.5"/>
                    <measurement group_id="O2" value="13.4" spread="1.4"/>
                    <measurement group_id="O3" value="13.2" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Protein</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="0.3"/>
                    <measurement group_id="O2" value="7.3" spread="0.4"/>
                    <measurement group_id="O3" value="7.3" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="0.3"/>
                    <measurement group_id="O2" value="4.4" spread="0.3"/>
                    <measurement group_id="O3" value="4.3" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>White Blood Cell and Platelet Count at Baseline, Day 8, and Day 28</title>
        <time_frame>baseline, day 8, and day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre Treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 day treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>White Blood Cell and Platelet Count at Baseline, Day 8, and Day 28</title>
          <units>k/uL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>White Blood Cell</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="1.6"/>
                    <measurement group_id="O2" value="6.1" spread="1.4"/>
                    <measurement group_id="O3" value="6.2" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelet Count</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="263" spread="59"/>
                    <measurement group_id="O2" value="262" spread="63"/>
                    <measurement group_id="O3" value="271" spread="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Alkaline Phosphatase, Alanine Transaminase , and Aspartate Transaminase at Baseline, Day 8, and Day 28</title>
        <time_frame>baseline, day 8, and day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre Treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 day treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Alkaline Phosphatase, Alanine Transaminase , and Aspartate Transaminase at Baseline, Day 8, and Day 28</title>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Alkaline Phosphatase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" spread="16"/>
                    <measurement group_id="O2" value="66" spread="17"/>
                    <measurement group_id="O3" value="67" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>aspartate transaminase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" spread="6"/>
                    <measurement group_id="O2" value="22" spread="18"/>
                    <measurement group_id="O3" value="19" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>alanine transaminase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" spread="7"/>
                    <measurement group_id="O2" value="15" spread="6"/>
                    <measurement group_id="O3" value="18" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serum Sodium, Potassium, and Carbon Dioxide at Baseline Day 8 and Day 28</title>
        <time_frame>baseline, day 8, and day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre Treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 day treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Sodium, Potassium, and Carbon Dioxide at Baseline Day 8 and Day 28</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Sodium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140" spread="1"/>
                    <measurement group_id="O2" value="140" spread="2"/>
                    <measurement group_id="O3" value="140" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="0.2"/>
                    <measurement group_id="O2" value="4.1" spread="0.3"/>
                    <measurement group_id="O3" value="4.0" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>carbon dioxide</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" spread="2"/>
                    <measurement group_id="O2" value="24" spread="2"/>
                    <measurement group_id="O3" value="24" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Resting Energy Expenditure (REE) and Metabolic Rate at Baseline Day 8 an Day 28</title>
        <time_frame>Baseline, day 8, and day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre Treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 day treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Resting Energy Expenditure (REE) and Metabolic Rate at Baseline Day 8 an Day 28</title>
          <units>kilocalories/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Resting Energy Expenditure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1556.3" spread="274.5"/>
                    <measurement group_id="O2" value="1562.8" spread="221.4"/>
                    <measurement group_id="O3" value="1670.6" spread="333.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolic Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1653.1" spread="268.7"/>
                    <measurement group_id="O2" value="1665.2" spread="258.8"/>
                    <measurement group_id="O3" value="1668.4" spread="259.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Resting Energy Expenditure as a Percent of Predicted at Baseline, Day 8, and Day 28</title>
        <description>This values measures the amount of energy a person uses during rest and compares it the average expected number of someone who is the same gender, age, and race.</description>
        <time_frame>Baseline, day 8, and day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 0</title>
            <description>Baseline/Pre Treatment</description>
          </group>
          <group group_id="O2">
            <title>Day 8</title>
            <description>Immediately post 7 day treatment</description>
          </group>
          <group group_id="O3">
            <title>Day 28</title>
            <description>28 days post treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Resting Energy Expenditure as a Percent of Predicted at Baseline, Day 8, and Day 28</title>
          <description>This values measures the amount of energy a person uses during rest and compares it the average expected number of someone who is the same gender, age, and race.</description>
          <units>percent of age/gender predicted values</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.89" spread="9.48"/>
                    <measurement group_id="O2" value="95.67" spread="12.94"/>
                    <measurement group_id="O3" value="101.39" spread="10.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>0-28 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Day 0</title>
          <description>Baseline/Pre Treatment</description>
        </group>
        <group group_id="E2">
          <title>Day 8</title>
          <description>Immediately post 7 day treatment</description>
        </group>
        <group group_id="E3">
          <title>Day 28</title>
          <description>28 days post treatment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Carol De la Motte</name_or_title>
      <organization>Cleveland Clinic Foundation</organization>
      <phone>216 444-5374</phone>
      <email>delamoc@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

